HKHalil Gürhan Karabulut

Halil Gürhan Karabulut

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Halil Gürhan Karabulut has a total of 214 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cytogenetic Landscape of Complex Karyotypes Across Hematological Malignancies: Common and Disease‐Specific Patterns in a Large Single‐Center Cohort

    by Şule Altıner, Arzu Vicdan, Nüket Yürür Kutlay, Timur Tuncalı, Halil Gürhan Karabulut, Hatice Ilgın Ruhi

    Cytogenetics remains an important method for evaluating hematological malignancies. Although recurring chromosomal abnormalities correlate with subtypes, complex karyotype (CK) has strong prognostic value related to overall survival. Cytogenetic data of patients with CK detected at the Department of Medical Genetics, Ankara University Faculty of Medicine over 8 years were examined in this study. A total of 16 437 bone marrow or peripheral blood samples were analyzed cytogenetically. Among them, 385 samples corresponding to 318 patients (2.34%) had complex cytogenetic abnormalities. Demographic characteristics, age distribution, hematological diagnoses, and cytogenetic findings were retrospectively evaluated. Among 385 CK samples, 200 (52%) were males and 29 (8%) were in the pediatric age group (defined as 18 years). The mean age at CK detection was 9.14 years (median: 9) in pediatric patients and 57.12 years (median: 60) in adults. Survival analysis showed that 33.77% of patients died within a mean of 7.55 months (median: 4) after CK detection. The consistent detection of chromosome 17p abnormalities across all groups (22% of patients) represented one of the most frequent shared cytogenetic findings in this CK cohort. Disease‐specific alterations were most common in multiple myeloma with chromosome 1 abnormalities being predominant (75%), whereas alterations of chromosomes 5 and 7 predominated in acute myeloid leukemia (61%) and myelodysplastic syndromes (50%). Cytogenetic findings suggestive of a monosomal karyotype were observed frequently in multiple myeloma (35.5%). Comparison of cytogenetic and FISH findings showed that targeted FISH panels frequently fail to detect karyotypical complexity, and diagnostic yield varies significantly among disease groups. In multiple myeloma, plasma cell‐enriched samples are more effective in detecting CK with FISH analysis compared to conventional bone marrow samples. CK remains a significant cytogenetic marker in hematological malignancies. Although genome‐wide molecular methods are increasingly available, conventional cytogenetic analysis remains more accessible in practice. This study demonstrates the value of conventional cytogenetics in CK detection and provides one of the most comprehensive datasets from Turkey.

  • Open Access

    Fifty Years of Misdiagnosis: Two Sisters with X-Linked Hypophosphatemia Misdiagnosed as Achondroplasia

    by Esra Eraslan Aydemir, Şerife Özkarakoç Ertürk, Can Berk Leblebici, Halil Gürhan Karabulut, Özgür Demir

    X-linked hypophosphatemia (XLH) is the most common inherited form of hypophosphatemic rickets, caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (PHEX) gene. Despite its distinct clinical and biochemical features, XLH can be misdiagnosed as achondroplasia because of overlapping skeletal manifestations. Two sisters, aged 53 and 60 years, who were misdiagnosed with achondroplasia for more than 5 decades were later diagnosed with XLH. Both patients presented with diffuse bone pain, severe skeletal deformities, including coxa vara with shepherd’s crook deformity and femoral bowing and a history of spontaneous dental abscesses. Laboratory testing revealed hypophosphatemia with normocalcemia. Family history showed an X-linked dominant inheritance pattern, with an affected father, all 4 sisters affected, and 3 unaffected brothers—inconsistent with achondroplasia. Whole-exome sequencing identified a novel heterozygous PHEX variant, c.207_212del (p.K69_V70del), classified as a variant of uncertain significance (VUS) per American College of Medical Genetics (ACMG) guidelines. Notably, the first patient had undergone parathyroidectomy 24 years earlier, likely reflecting tertiary hyperparathyroidism as a long-term complication of undiagnosed XLH. This report highlights that careful evaluation of family history, combined with simple biochemical tests, can prevent decades of misdiagnosis and its associated morbidity. Cite this article as: Aydemir EE, Ertürk Ş., Leblebici CB, Karabulut HG, Demir. Fifty years of misdiagnosis: two sisters with X-linked hypophosphatemia misdiagnosed as achondroplasia. Endocrinol Res Pract. 2026;30(3):213-216.

  • Open Access

    Mutation analysis of the FOXL2 and BMP15 genes in patients with premature ovarian insufficiency

    by Mehmet Burak Mutlu, Vehap Topçu, Şerife Esra Çetinkaya, Yaprak Üstün, Abdullatif Bakır, Cem Somer Atabekoğlu, Hatice Ilgın Ruhi, Halil Gürhan Karabulut

    Mutation analysis of the FOXL2 and BMP15 genes in patients with premature ovarian insufficiency - Turkish Journal of Obstetrics and Gynecology

  • Open Access

    Genetic Analysis of RASD1 as a Candidate Gene for Schizophrenia

    by Ceren Damla Durmaz, Halil Gürhan Karabulut, Meram Can Saka, Ceren Sucularlı, Güvem Gümüş Akay, Cem Atbaşoğlu, Hatice Ilgın Ruhi

    Background: RASD1 encodes Dexamethasone-induced Ras-related protein 1 (Dexras1), a protein with a critical role in signal transduction in neurons. There is a strong suspicion that dysfunction of Dexras1 might contribute to the pathogenesis of neuropsychiatric diseases. Related to its functions in intracellular signaling pathways, Dexras1 has a potential role in the etiology of schizophrenia because of its close interaction with NOS1, NOS1AP, and NMDAR, which have previously been associated with schizophrenia. Aims: To investigate the association of RASD1 variants with schizophrenia in a selected cohort from Turkey. Study Design: A case-control study. Methods: We performed targeted sequencing for the two exons, single intron, and untranslated regions of RASD1 gene in 200 individuals with schizophrenia and 100 healthy controls of Turkish origin. Results: Two rare variants, RASD1 (NM_016084.5): c.722A>T and c*31G>A were identified in individuals with schizophrenia but not in any controls. The c.722A>T was found in a single individual with schizophrenia and is a missense heterozygous variant in the second exon of RASD1, which is extremely rare in GnomAD. The other variant, c*31G>A, which was found in another individual from this schizophrenia cohort, has not been reported previously. Seven previously identified common single nucleotide polymorphisms were also detected; however, they were not significantly associated with schizophrenia in this study cohort. Conclusion: Our findings suggest that rare variants ofRASD1 might be contributing to the etiopathogenesis of schizophrenia. Further studies are needed to elucidate the underlying mechanism of this association.


  • Extending Phenotypic Spectrum of 17q22 Microdeletion: Growth Hormone Deficiency

    by Ceren Damla Durmaz, Şule Altıner, Elifcan Taşdelen, Halil Gürhan Karabulut, Hatice Ilgın Ruhi

    Background: The 17q22 contiguous microdeletion syndrome is a recently described chromosomal disorder. Clinical features are heterogeneous because of variable deletion sizes. Clinical report: We present a child with delayed psychomotor development, dysmorphic features (prominent posterior rotated ears, upturned nose, thin upper lip, smooth philtrum, high palate), vesicoureteral reflux and growth hormone deficiency. 1.53 Mb loss at the 17q22 chromosome region in the proband was the responsible for the phenotype. Conclusion: In the few cases of interstitial 17q22 deletion in the literature, this is the first with growth hormone deficiency. This may contribute to the phenotypic spectrum of 17q22 microdeletion syndrome. As the reported cases increase, we believe that genotype-phenotype correlation will be better illuminated.


  • Cytogenetic, Molecular, and Phenotypic Characterization of a Patient with de novo Derivative Chromosome 18 and Review of the Literature

    by Ezgi Gökpınar İlI, Şule Altıner, Halil G. Karabulut

    We present a patient with a de novo derivative chromosome 18 which includes a terminal deletion of 18p and a terminal duplication of 18q accompanied by a cryptic duplication of 18p. The girl had mild dysmorphic features such as micro-retrognathia, upslanted palpebral fissures, bilateral epicanthus, high palate, low-set ears, short neck, and full cheeks. She also had an H-type tracheoesophageal fistula which required surgery. Her cognitive and motor skills were delayed. Karyotype analysis showed an additional segment on the short arm of chromosome 18. Chromosomal microarray revealed a 7.3-Mb terminal loss from 18p11.32 to 18p11.23, a 22.2-Mb terminal gain from 18q21.31 to 18q23, and a 3.9-Mb interstitial gain from 18p11.22 to 18p11.21. We hypothesize that the mother has gonadal mosaicism for normal chromosome 18, der(18)dup(p11.22p11.21), and der(18)dup(p11. 22p11.21)inv(18)(p11.22q21.31), or both the terminal del/dup and the interstitial duplication occurred simultaneously.


  • Primary Hypertrophic Osteoarthropathy Mimicking Juvenile Idiopathic Arthritis: A Novel SLCO2A1 Mutation and Imaging Findings

    by Murat Torgutalp, Ceren D. Durmaz, Halil G. Karabulut, Wenke Seifert, Denise Horn, Zehra Akkaya, Murat Turgay

    Primary hypertrophic osteoarthropathy (PHO), also known as pachydermoperiostosis, is a rare, multisystemic, autosomal recessive condition typically presenting with digital clubbing, osteoarthropathy, and various skin manifestations. Radiographs show distinctive periosteal reaction and thickening along the long bones. PHO is caused by homozygous mutations in the HPGD gene in chromosome 4q34.1 or the SLCO2A1 gene in 3q22.1q22.2. Here, we report on a 20-year-old male with enlarged and swollen joints with arthralgia, palmoplantar hyperhidrosis, and large hands and feet with marked digital clubbing. We also present radiographic, MRI, and ultrasonographic features of the case. These clinical and imaging findings were compatible with the diagnosis of PHO, and a novel homozygous mutation, c.576C>G, p.Ile192Met, was found in SLCO2A1.


  • Expression of Survivin and Its Splice Variants in Pediatric Acute Lymphoblastic Leukemia

    by Efsun Eren-Keleş, Halil Gürhan Karabulut, Hasan Fatih Çakmaklı, Başak Adaklı, Serdar Kenan Köse, Handan Uğur-Dinçaslan, Gülsan Yavuz, Mehmet Ertem, Ajlan Tükün

    Aims: Survivin is involved in the inhibition of apoptosis and the regulation of cell division. In addition to wild-type survivin (survivin-wt), at least four splice variants with differential functions (ΔEx3 and 3B antiapoptotic, and 2α and 2B proapoptotic) have been identified. Survivin is highly expressed in several cancers, including hematological malignancies. Although acute lymphoblastic leukemia (ALL) is the most frequent malignancy in children, studies that investigated survivin expression in ALL are limited, and there is no study on 3B and 2α expression in ALL. Therefore the expression of survivin-wt and its splice variants was investigated in pediatric B-cell ALL patients. Materials and Methods: The expression of survivin-wt and its four splice variants was investigated by quantitative real-time polymerase chain reaction in archival RNA samples of 35 pediatric B-cell ALL patients. Patients were divided into high- and standard-risk groups according to age, white blood cell count, extramedullary involvement, and genetic risk factors; expression of survivin variants was compared between these two risk groups. Results: We found that the ratio of survivin-ΔEx3/wild type (WT) expression was higher in the low-risk group than in the high-risk group. Conclusion: Comparative analysis between the high- and low-risk B-cell ALL groups indicated that survivin-ΔEx3/WT expression ratio could potentially be used in risk classification for pediatric B-cell ALL.


  • Autosomal Recessive Oculodentodigital Dysplasia: A Case Report and Review of the Literature

    by Elifcan Taşdelen, Ceren D. Durmaz, Halil G. Karabulut

    Oculodentodigital dysplasia (ODDD) is a rare condition characterized by a typical facial appearance and variable findings of the eyes, teeth, and fingers. ODDD is caused by mutations in the GJA1 gene in chromosome 6q22 and inherited in an autosomal dominant manner in the majority of the patients. However, in recent clinical reports, autosomal recessive ODDD cases due to by GJA1 mutations were also described. Here, we report on a 14-year-old boy with microphthalmia, microcornea, narrow nasal bridge, hypoplastic alae nasi, prominent columnella, hypodontia, dental caries, and partial syndactyly of the 2nd and 3rd toes. These clinical findings were concordant with the diagnosis of ODDD, and a novel homozygous mutation (c.442C>T, p.Arg148Ter) was determined in the GJA1 gene leading to a premature stop codon. His phenotypically normal parents were found to be carriers of the same mutation. This is the third family in the literature in which ODDD segregates in an autosomal recessive manner.


  • A Novel PORCN Frameshift Mutation Leading to Focal Dermal Hypoplasia: A Case Report

    by Ceren D. Durmaz, John McGrath, Lu Liu, Halil G. Karabulut

    Focal dermal hypoplasia (FDH), also known as Goltz-Gorlin syndrome, is a rare, multisystemic, X-linked dominant genodermatosis characterized by defective development of mesodermal and ectodermal tissues. Major clinical features of the disorder are skin manifestations, skeletal defects, and developmental eye abnormalities. FDH is caused by heterozygous mutations in the PORCN gene located at Xp11.23, and 90% of individuals with FDH are females. Here, we report a female patient with cutaneous changes, multiple eye anomalies, short stature, and ectrodactyly of the right foot. These clinical findings were compatible with the diagnosis of FDH, and a novel mutation, NM_022825.3:c.488delG was found in the PORCN gene causing a premature stop codon.